Injective CEO meets US officials to advance blockchain tokenization
Business · 16 October 2026
Written by AI from multiple news reports
Injective CEO Eric Chen met with senior US officials on Wednesday to talk about tokenization and blockchain finance. The meetings focused on how these services can work within US rules and regulations.
Injective has already taken steps to enter the US market. Its institutional arm became a registered transfer agent with the SEC in August. The company has also filed two ETF applications with the SEC, with updated documents submitted in September. Chen has said he expects at least one Injective ETF to reach US investors before 2027.
The company is also preparing for European markets. It published a white paper in line with the EU's MiCA rules. The INJ token was trading close to $9 at the time of reporting, up from a recent low of $6.59.